Atul Pande's Net Worth
$10.9 Million
Who is Atul Pande?
Atul Pande has an estimated net worth of $10.9 Million. This is based on reported shares across multiple companies, which include Karuna Therapeutics, Inc., Immunovant, Inc., and Axovant Sciences Ltd..
SEC CIK
Atul Pande's CIK is 0001643071
Past Insider Trading and Trends
2021 was Atul Pande's most active year for acquiring shares with 15 total transactions. Atul Pande's most active month to acquire stocks was the month of March. 2021 was Atul Pande's most active year for disposing of shares, totalling 22 transactions. Atul Pande's most active month to dispose stocks was the month of February. 2022 saw Atul Pande paying a total of $80,000.00 for 155,945 shares, this is the most they've acquired in one year. In 2024 Atul Pande cashed out on 28,894 shares for a total of $6,259,679.20, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Karuna Therapeutics, Inc. (KRTX) No price found
InvestorAtul Pande used to own units in Common Stock but no longer holds any shares there. From 2019 to 2024 Atul Pande acquired a total of 74,204 shares in Karuna Therapeutics, Inc. at a cost of $638,884.88, Atul also disposed a total of 74,204 shares of Karuna Therapeutics, Inc. equalling to $7,829,994.96.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -990.00 |
$330.00 | -$326,700.00 |
0
|
Mar 18
| |||
Form 4
|
∞
| 990 |
—
|
—
| 990 |
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
$63.40 | -$237,000.00 |
0
|
Scheduled
|
Feb 1
| ||
Form 4
|
—
|
0
|
$73.22 | -$286,100.00 |
0
|
Scheduled
|
Jan 3
| ||
Form 4
|
—
|
0
|
$71.87 | -$279,325.00 |
0
|
Scheduled
|
Dec 1
| ||
Form 4
|
—
|
0
|
$76.33 | -$301,675.00 |
0
|
Scheduled
|
Nov 1
| ||
Form 4
|
—
|
0
|
$68.36 | -$261,800.00 |
0
|
Scheduled
|
Oct 1
| ||
Form 4
|
—
|
0
|
$66.91 | -$254,550.00 |
0
|
Scheduled
|
Sep 1
| ||
Form 4
|
—
|
0
|
$65.09 | -$245,425.00 |
0
|
Scheduled
|
Aug 2
| ||
Form 4
|
—
|
0
|
$64.33 | -$241,650.00 |
0
|
Scheduled
|
Jul 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
$63.72 | -$238,600.00 |
0
|
Scheduled
|
Jun 1
| ||
Form 4
|
—
|
0
|
$65.66 | -$496,550.00 |
0
|
Scheduled
|
Apr 1 - May 3
| ||
Form 4
|
—
|
0
|
$70.72 | -$273,575.00 |
0
|
Scheduled
|
Mar 1
| ||
Form 4
|
—
|
0
|
$58.00 | -$210,000.00 |
0
|
Scheduled
|
Feb 1
| ||
Form 4
|
—
|
0
|
$47.78 | -$512,660.08 |
0
|
Scheduled
|
Dec 14
| ||
Form 4
|
—
|
0
|
$49.88 | -$469,600.00 |
0
|
Scheduled
|
Nov 12
| ||
Form 4
|
—
|
0
|
$43.96 | -$410,400.00 |
0
|
Scheduled
|
Nov 3
| ||
Form 4
|
—
|
0
|
$43.96 | -$410,400.00 |
0
|
Scheduled
|
Sep 16
| ||
Form 4
|
—
|
0
|
$43.96 | -$410,400.00 |
0
|
Scheduled
|
Aug 12
| ||
Form 4
|
—
|
0
|
$43.96 | -$410,400.00 |
0
|
Scheduled
|
Aug 12
| ||
Form 4
|
—
|
0
|
$49.18 | -$462,550.00 |
0
|
Scheduled
|
Jul 13
| ||
Form 4
|
—
|
0
|
$48.10 | -$451,750.00 |
0
|
Scheduled
|
Jun 12
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Immunovant, Inc. (IMVT) Snapshot price: $34
InvestorAtul Pande owns 94,413 units of Common Stock which is worth $3,210,042.00. From 2019 to 2024 Atul Pande acquired a total of 106,763 shares in Immunovant, Inc., Atul also disposed a total of 12,350 shares of Immunovant, Inc. equalling to $490,667.50.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +13.53% | 11.26K |
—
|
—
| 94.41K |
Apr 2
| |||
Form 4
| -12.93% | -12.35K |
$39.73 | -$490,667.50 | 83.16K |
Scheduled
|
Dec 1
| ||
Form 4
| +15.09% | 12.52K |
—
|
—
| 95.51K |
Apr 12
| |||
Form 4
| +300.00% | 15K |
$5.60 | $84,000.00 | 20K |
Sep 30
| |||
Form 4
| +34.01% | 21.06K |
—
|
—
| 82.98K |
Aug 17
| |||
Form 4
| +54.04% | 21.73K |
—
|
—
| 61.93K |
Jan 10
| |||
Form 4
| +12.44% | 5K |
$7.98 | $39,900.00 | 45.2K |
Aug 13
| |||
Form 4
| +62.75% | 15.5K |
—
|
—
| 40.2K |
Mar 19
| |||
Form 4
|
∞
| 24.7K |
—
|
—
| 24.7K |
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Axovant Sciences Ltd. (SIOX) Snapshot price: $0.45
InvestorAtul Pande owns 3,370 units of Common Stock which is worth $1,516.50. In the year 2015 Atul Pande acquired a total of 3,370 shares in Axovant Sciences Ltd. at a cost of $17,595.44.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
Form 4
| +42.79% | 10K |
$2.34 | $23,399.00 | 33.37K |
Nov 24
| |||
Form 4
| +74.79% | 10K |
$2.73 | $27,290.00 | 23.37K |
Jul 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
Form 4
| +296.74% | 10K |
$1.78 | $17,844.00 | 13.37K |
Mar 16
| |||
Form 4
|
∞
| 3.37K |
$5.22 | $17,595.44 | 3.37K |
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||